Clinical Trial

High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease

Recruiting
View on ClinicalTrials.gov →
Summary
Parkinson's disease (PD) impacts different types of neural oscillations in the brain, including beta (13-30Hz) and gamma oscillations (30-80Hz), which contributes to PD's cardinal symptoms of resting tremor, rigidity, bradykinesia (slowness of movement), and gait instability. The investigators' lab has developed a non-invasive method of increasing gamma power in the brain using Gamma Entrainment Using Sensory Stimulation (GENUS) through light, sound, and tactile stimulation devices. For this study, 40 participants with mild Parkinson's disease will be recruited, and the investigators will assess their brain waves with electroencephalogram (EEG) before, during, and after light, sound, and tactile stimulation to determine the safety, feasibility, and optimization of GENUS as a potential therapy in the PD population.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-02-24; most recent amendment 2026-03-30.
Trial Details
NCT Number NCT05268887
Lead Sponsor Massachusetts Institute of Technology
Conditions Parkinson Disease
Enrollment 40 participants
Start Date 2022-02-09
Primary Completion 2027-11-01 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-31